{"id":12024,"date":"2019-02-18T18:53:27","date_gmt":"2019-02-18T18:53:27","guid":{"rendered":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/?p=12024"},"modified":"2019-02-18T18:53:27","modified_gmt":"2019-02-18T18:53:27","slug":"fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront","status":"publish","type":"post","link":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/","title":{"rendered":"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice \u2013 A Discussion with Leaders on the Forefront"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.thermofisher.com\/blog\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg\" style=\"float: right\" width=\"318\" height=\"93\" title=\"Precision LBx\" class=\"alignright\" \/><\/p>\n<p>The research benefits of liquid biopsy are well known and have been in practice for some time. While the impact of liquid biopsy research in potentially treating cancer patients is well established, we are now at the threshold of making the transition into routine clinical practice. Join us on February 19th from 4 &ndash; 5 PM at the <a href=\"http:\/\/lbx-summit.com\/\" target=\"_blank\">Precision LBx Conference<\/a> in San Diego, CA. We have assembled a distinguished panel that will discuss how liquid biopsy assays are moving from the research environment into routine clinical practice.<\/p>\n<p><strong>Meet our panelists:<\/strong><br \/>Dr. Madhu Ghosh (Moderator) &ndash; Senior Director, Strategic Alliances, Thermo Fisher Scientific<br \/>Dr. Raja Luthra (Panelist) &ndash; Director, Molecular Diagnostics Lab, MD Anderson Cancer Center<br \/>Dr. Gina Waller (Panelist) &ndash; Senior Vice President, Clinical Division, NeoGenomics <br \/>Dr. Luca Quagliata (Panelist) &ndash; Senior Director, Medical Affairs, Thermo Fisher Scientific<\/p>\n<p>Dr. Raja Luthra will share her perspective as the Director of the Molecular Diagnostics Lab at MD Anderson Cancer Center, a leading institute in demonstrating the clinical application of liquid biopsy assays in treating cancer patients. Dr. Luca Quagliata will share his perspective as the Global Director of Medical Affairs for Thermo Fisher Scientific and also provide insights gleaned from his recent work at the University of Basel. Dr. Gina Walker will describe progress in the clinical application of liquid biopsy based on the use, to date, of NeoGenomics liquid biopsy assays. Dr. Madhu Ghosh, Senior Director of Strategic Alliances at Thermo Fisher Scientific, will provide an overview of partnerships across the world that are enabling the adoption of liquid biopsies into clinical care &ndash; highlighting key partners in the US, Europe, and Singapore.<\/p>\n<p>Our discussion will start with the benefits to the patient. In research settings, some of the most exciting and compelling areas relate to the potential of liquid biopsy assays to change the clinical experience for patients &ndash; both in terms of the discomfort associated with traditional biopsy, and the costs associated with traditional diagnostic imaging screening protocols. Can implementation of liquid biopsy assays replace some of these traditional protocols and enhance the patient experience?<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" height=\"158\" src=\"https:\/\/www.thermofisher.com\/blog\/wp-content\/uploads\/sites\/9\/2019\/02\/liquid20biopsy.jpg\" style=\"float: right\" width=\"288\" \/><\/p>\n<p>Our panelists will discuss the possibilities in clinical treatment that liquid biopsy assays provide in terms of the overall diagnostic and treatment potential to improve outcomes. We will share the promises and challenges of earlier detection, improved tumor and cancer progression monitoring, and improved timeliness of tumor responsiveness to treatment options, including earlier signs of resistance.<\/p>\n<p>Our panelists will discuss the practical challenges of adoption into more routine clinical practice including reimbursement and education of the community. Each panelist has insights in this area from first-hand experience; some have experience working with several institutions. Advice on ways to overcome challenges and anticipate solutions in the clinical, research, and administrative environment will be covered.<\/p>\n<p>Our panelists will compare interests in liquid biopsy between pharmaceutical companies and clinical practice. They will also discuss the role liquid biopsy plays in profiling solid tumors.<\/p>\n<p>Please join us for the very latest thinking, practical advice, and forward-looking guidance from leaders and experienced practitioners in the field of liquid biopsy. This discussion will be of interest to anyone who is looking to bring liquid biopsy assays into clinical practice as well as anyone who is interested in the current state and future opportunities in liquid biopsy. Our panelists will share their own experience in navigating the very same challenges that others face in the clinical adoption of liquid biopsy assays as an important development in how we potentially treat cancer patients.<\/p>\n<p>Thermo Fisher Scientific believes in the importance of bringing together experts that are working through the kinds of challenges and opportunities that clinicians and clinical scientists face as they embark on integrating liquid biopsy into their own clinical practice. We have fostered an environment where candid professional discussions may help elevate new technology and solutions and potentially impact patient lives. We are excited about the opportunity to bring this panel of thought leaders to share the latest in making liquid biopsy a practical and routine tool to improve the treatment of cancer and the lives of patients. Please join us and be part of the discussion! If you are unable to join, please stay tuned for a debrief after the event.<\/p>\n<p><!-- BEGIN KAPOST ANALYTICS CODE --><\/p>\n<p><!--\nvar _kaq = _kaq || [];\n_kaq.push([2, \"5c6ae17f7776b3003a000067\", \"5674227b963491538f00011d\"]);\n(function(){\nvar ka = document.createElement(\"script\"); ka.async=true; ka.id=\"ka_tracker\";\nka.src = (document.location.protocol == \"https:\" ? \"https\" : \"http\") + \":\/\/analytics.kapost.com\/ka.js\";\nvar s = document.getElementsByTagName(\"script\")[0]; s.parentNode.insertBefore(ka, s);\n})();\n\/\/--><\/p>\n<p><!-- END KAPOST ANALYTICS CODE --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The research benefits of liquid biopsy are well known and have been in practice for some time. While the impact of liquid biopsy research in potentially treating cancer patients is well established, we are now at the threshold of making the transition into routine clinical practice. Join us on February 19th from 4 &ndash; 5<\/p>\n","protected":false},"author":120,"featured_media":12023,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_monsterinsights_skip_tracking":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[54,113],"tags":[],"division":[],"class_list":{"0":"post-12024","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-cancer-research","8":"category-events-and-tradeshows","9":"entry"},"_selected_authors":"","_selected_reviewers":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice<\/title>\n<meta name=\"description\" content=\"Panel at the 2019 Precision LBx Conference discussing how liquid biopsy assays are moving from the research environment into routine clinical practice.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice \u2013 A Discussion with Leaders on the Forefront\" \/>\n<meta property=\"og:description\" content=\"Panel at the 2019 Precision LBx Conference discussing how liquid biopsy assays are moving from the research environment into routine clinical practice.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/\" \/>\n<meta property=\"og:site_name\" content=\"Behind the Bench\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thermofisher\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-18T18:53:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"818\" \/>\n\t<meta property=\"og:image:height\" content=\"238\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Behind The Bench Staff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:site\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Behind The Bench Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/\"},\"author\":{\"name\":\"Behind The Bench Staff\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/9bbb2d67616274d3d4a21a584f7f4a0c\"},\"headline\":\"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice \u2013 A Discussion with Leaders on the Forefront\",\"datePublished\":\"2019-02-18T18:53:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/\"},\"wordCount\":716,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/02\\\/precision20lbx.jpg\",\"articleSection\":[\"Cancer Research\",\"Events and Tradeshows\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/\",\"url\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/\",\"name\":\"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/02\\\/precision20lbx.jpg\",\"datePublished\":\"2019-02-18T18:53:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/9bbb2d67616274d3d4a21a584f7f4a0c\"},\"description\":\"Panel at the 2019 Precision LBx Conference discussing how liquid biopsy assays are moving from the research environment into routine clinical practice.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/02\\\/precision20lbx.jpg\",\"contentUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/02\\\/precision20lbx.jpg\",\"width\":818,\"height\":238},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice \u2013 A Discussion with Leaders on the Forefront\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\",\"name\":\"Behind the Bench\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/9bbb2d67616274d3d4a21a584f7f4a0c\",\"name\":\"Behind The Bench Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g\",\"caption\":\"Behind The Bench Staff\"},\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/author\\\/behind-the-bench-staff\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice","description":"Panel at the 2019 Precision LBx Conference discussing how liquid biopsy assays are moving from the research environment into routine clinical practice.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/","og_locale":"en_US","og_type":"article","og_title":"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice \u2013 A Discussion with Leaders on the Forefront","og_description":"Panel at the 2019 Precision LBx Conference discussing how liquid biopsy assays are moving from the research environment into routine clinical practice.","og_url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/","og_site_name":"Behind the Bench","article_publisher":"https:\/\/www.facebook.com\/thermofisher","article_published_time":"2019-02-18T18:53:27+00:00","og_image":[{"width":818,"height":238,"url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg","type":"image\/jpeg"}],"author":"Behind The Bench Staff","twitter_card":"summary_large_image","twitter_creator":"@thermofisher","twitter_site":"@thermofisher","twitter_misc":{"Written by":"Behind The Bench Staff","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#article","isPartOf":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/"},"author":{"name":"Behind The Bench Staff","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/9bbb2d67616274d3d4a21a584f7f4a0c"},"headline":"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice \u2013 A Discussion with Leaders on the Forefront","datePublished":"2019-02-18T18:53:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/"},"wordCount":716,"commentCount":0,"image":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg","articleSection":["Cancer Research","Events and Tradeshows"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/","url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/","name":"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice","isPartOf":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#primaryimage"},"image":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg","datePublished":"2019-02-18T18:53:27+00:00","author":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/9bbb2d67616274d3d4a21a584f7f4a0c"},"description":"Panel at the 2019 Precision LBx Conference discussing how liquid biopsy assays are moving from the research environment into routine clinical practice.","breadcrumb":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#primaryimage","url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg","contentUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg","width":818,"height":238},{"@type":"BreadcrumbList","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/fostering-the-adoption-of-liquid-biopsy-in-routine-clinical-practice-a-discussion-with-leaders-on-the-forefront\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admin.acceleratingscience.com\/behindthebench\/"},{"@type":"ListItem","position":2,"name":"Fostering the Adoption of Liquid Biopsy in Routine Clinical Practice \u2013 A Discussion with Leaders on the Forefront"}]},{"@type":"WebSite","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website","url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/","name":"Behind the Bench","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admin.acceleratingscience.com\/behindthebench\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/9bbb2d67616274d3d4a21a584f7f4a0c","name":"Behind The Bench Staff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/52d5c16ece4bd1c0a49a63521c2b6a25c54a3f0c33f7afed215ba7e0cdff69e3?s=96&d=mm&r=g","caption":"Behind The Bench Staff"},"url":"https:\/\/admin.acceleratingscience.com\/author\/behind-the-bench-staff\/"}]}},"taxonomy_info":{"category":[{"value":54,"label":"Cancer Research"},{"value":113,"label":"Events and Tradeshows"}]},"featured_image_src_large":["https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg",760,221,false],"author_info":{"display_name":"Behind The Bench Staff","author_link":"https:\/\/admin.acceleratingscience.com\/author\/behind-the-bench-staff\/"},"comment_info":0,"category_info":[{"term_id":54,"name":"Cancer Research","slug":"cancer-research","term_group":0,"term_taxonomy_id":54,"taxonomy":"category","description":"","parent":0,"count":142,"filter":"raw","meta":[],"cat_ID":54,"category_count":142,"category_description":"","cat_name":"Cancer Research","category_nicename":"cancer-research","category_parent":0},{"term_id":113,"name":"Events and Tradeshows","slug":"events-and-tradeshows","term_group":0,"term_taxonomy_id":113,"taxonomy":"category","description":"","parent":0,"count":89,"filter":"raw","meta":[],"cat_ID":113,"category_count":89,"category_description":"","cat_name":"Events and Tradeshows","category_nicename":"events-and-tradeshows","category_parent":0}],"tag_info":false,"jetpack-related-posts":[{"id":19579,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/liquid-biopsy-cancer-research-ngs-pcr\/","url_meta":{"origin":12024,"position":0},"title":"From Discovery to Monitoring: How Sequencing and PCR Work Together in Oncology Research","author":"Behind The Bench Staff","date":"March 24, 2026","format":false,"excerpt":"Scientific, joins the Absolute Gene-ius podcast to discuss how molecular technologies are advancing precision oncology research. With experience spanning clinical laboratory research, digital PCR research applications, and next-generation sequencing (NGS), Dr. Sollweck shares how scientists are addressing critical unmet needs in cancer research. From liquid biopsy research strategies to minimal\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Sollweck-headshot-200x250_Jordan-Ruggieri.jpeg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":19805,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/liquid-biopsy-workflow-standardization\/","url_meta":{"origin":12024,"position":1},"title":"Improving the Reliability of Liquid Biopsy in Real-World Settings Through Workflow Standardization: A Discussion with Dr. Matteo Allegretti","author":"Ashleigh Barlow","date":"June 18, 2026","format":false,"excerpt":"Liquid biopsy offers a powerful, noninvasive way to detect and track cancer, but ensuring reliability in real-world settings remains a key hurdle. Variability in workflows and the need for robust verification steps limit widespread adoption. Dr. Matteo Allegretti, Senior Researcher at the Translational Oncology Research Unit at the IRCCS Regina\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Research scientist operating laboratory equipment during liquid biopsy and biomarker research.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":19345,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/precision-oncology-diagnostics\/","url_meta":{"origin":12024,"position":2},"title":"The Expanding Role of Molecular Diagnostics in Precision Oncology","author":"Behind The Bench Staff","date":"January 13, 2026","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=F6FfHIizJBY For Dr. Harald Bartsch, a clinical pathologist in southern Bavaria, molecular diagnostic tools have become an indispensable part of his arsenal. \u201cI believe molecular diagnostics play a crucial role in modern oncology, and I see this as the direction everything is headed,\u201d says Dr. Bartsch. While immunohistochemistry remains central\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Clinical Pathologist in a Molecular Diagnostics Laboratory","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19911,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/multiplex-mirna-profiling-precision-oncology\/","url_meta":{"origin":12024,"position":3},"title":"A scalable multiplex miRNA profiling workflow for precision oncology research","author":"Ashleigh Barlow","date":"August 18, 2026","format":false,"excerpt":"The promise of precision oncology rests on our ability to reliably monitor tumor biology in real time. Circulating microRNAs (miRNAs) offer that opportunity, serving as potentially stable, non-invasive biomarkers linked to disease progression and therapeutic response; however, their adoption in routine practice remains constrained by technical hurdles. (1,2) Because cancer\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Scientist pipetting a laboratory sample during molecular biomarker research.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19509,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/cfdna-fragmentomics-analysis-qpcr-cancer-monitoring\/","url_meta":{"origin":12024,"position":4},"title":"qPCR-based fragmentomics for monitoring cancer disease progression","author":"Behind The Bench Staff","date":"March 5, 2026","format":false,"excerpt":"As fragmentomics gains momentum in cancer liquid biopsy research, attention is increasingly turning to how these structural cfDNA signals can be measured in a way that is both sensitive and practical. Established qPCR platforms offer an alternative to sequencing-based approaches for capturing fragment size information with high precision. Using a\u2026","rel":"","context":"In &quot;Bioinformatics&quot;","block_context":{"text":"Bioinformatics","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/bioinformatics\/"},"img":{"alt_text":"Scientist pipetting into a 96 well plate during qPCR workflow for cell free DNA fragmentomics analysis","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Picture1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Picture1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Picture1.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":19232,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/early-molecular-relapse-detection-dpcr\/","url_meta":{"origin":12024,"position":5},"title":"Following the Molecular Fingerprints of Cancer with Digital PCR","author":"Behind The Bench Staff","date":"November 11, 2025","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=vbta1TG617s For clinical researchers and scientists, the value of a biomarker depends on its accurate measurement and trackability over time. Digital PCR (dPCR) delivers both. At Tata Medical Center, Dr. Mayur Parihar, Senior Consultant in Hematology and Cytogenetics and Clinical Research Scientist at the Tata Translational Cancer Research Center, recognizes\u2026","rel":"","context":"In &quot;Cancer Research&quot;","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Pathologist preparing a molecular diagnostic sample in a clinical laboratory to support precision oncology decision-making.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/02\/precision20lbx.jpg","_links":{"self":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/12024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/users\/120"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/comments?post=12024"}],"version-history":[{"count":0,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/12024\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/media\/12023"}],"wp:attachment":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/media?parent=12024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/categories?post=12024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/tags?post=12024"},{"taxonomy":"division","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/division?post=12024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}